Ethan Shen Ph.D., CEO at YD Bio Ltd (YDES), bought 3,100 shares at $3.93 ($12K) on 2026-09-09, disclosed to the SEC on 2026-09-10.
CEO Ethan Shen Ph.D. purchased 3,100 shares for $12,183, signaling confidence in the company's recent momentum following its NASDAQ Composite inclusion. This insider buying comes as the stock has surged 34.31% over the past month, potentially indicating the CEO views the current valuation as attractive.
The stock is up 34.31% over the last 30 days and is currently trading 75.24% above its 52-week low of $2.10, though it remains 25.2% below the 52-week high of $4.92.
1) NASDAQ Composite Index inclusion on 2025-09-10 has driven a 31% price rise over the past month. 2) Business combination with Taiwan-based YD Biopharma to strengthen biopharmaceutical presence.
The stock is currently trading 25.2% below its 52-week high of $4.92, suggesting the recent rally may be approaching a resistance level.
Nothing distinguishes this filing.
| Filing → |